Please note that this product was withdrawn from the Community Register of designated Orphan Medicinal Products in October 2019 on request of the Sponsor.

The sponsorship was transferred to Immune Design Ltd, United Kindom, in August 2016.

On 16 October 2017, orphan designation (EU/3/17/1924) was granted by the European Commission to Immune Design Ltd, United Kingdom, for glucopyranosyl lipid A stable emulsion (also known as G100) for the treatment of follicular lymphoma.

Key facts

Active substance
Glucopyranosyl lipid A
Disease / condition
Treatment of follicular lymphoma
Date of first decision
EU designation number

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Sponsor's contact details

Immune Design Ltd
21 Holborn Viaduct
London EC1A 2DY
United Kingdom
Tel. +44 (0) 2031 005 102
Contact us

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating